News, views and contacts from the global Hospital industry

BD Diagnostic Systems Molecular: Press Releases

Make An Enquiry

BD Acquires GenCell Biosystems Monday, October 13, 2014 by BD Diagnostic Systems Molecular Becton, Dickinson and Company (BD) has announced its acquisition of GenCell...

AutoShield™ Duo Pen Needle Available through Retail Pharmacies Wednesday, August 06, 2014 by BD Diagnostic Systems Molecular BD Medical has announced the nationwide retail pharmacy launch of BD AutoShield™ Duo at the annual meeting for the American Association of Diabetes Educators in Orlando,...

BD Expands its Suite of Open System Solutions on the Fully Automated BD MAX™ Platform Monday, August 04, 2014 by BD Diagnostic Systems Molecular BD Diagnostics has announced the availability of the Total Nucleic Acid (TNA) suite of reagents for the BD MAX...

New Chlamydia and Gonorrhea Assays on the BD Viper™ LT System Receive CE/IVD Marking Monday, July 28, 2014 by BD Diagnostic Systems Molecular BD Diagnostics has announced it achieved CE/IVD Marking for the BD ProbeTec™ chlamydia trachomatis (CT), Qx Amplified DNA Assay and the BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified...

Novel Molecular Assay for Pre-Surgical Screening Detects Newly Discovered MRSA Strains Monday, September 02, 2013 by BD Diagnostic Systems Molecular BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today the availability of the CE-marked BD MAX™ StaphSR assay with eXTended Detection Technology in Europe for...

Menu of Partner Assays for the BD MAX™ System Continues to Expand Thursday, June 27, 2013 by BD Diagnostic Systems Molecular BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), and Diagenode, an international biotech company based in Belgium, have announced the...

First Partner Assay on the BD MAX™ System Launches in Europe Wednesday, November 14, 2012 by BD Diagnostic Systems Molecular BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), and Diagenode SA, an international biotech company based in Belgium, announced today...